After attending this session I can now demonstrate the identified learning objectives *

	Yes	No
Describe the data regarding use of specific biologics in AERD and ABPA	Describe the data regarding use of specific biologics in AERD and ABPA - Yes	Describe the data regarding use of specific biologics in AERD and ABPA - No
Describe the patient features and endotype mechanisms that may influence the choice of biologics in these endotypes	Describe the patient features and endotype mechanisms that may influence the choice of biologics in these endotypes - Yes	Describe the patient features and endotype mechanisms that may influence the choice of biologics in these endotypes - No

The session format and teaching technique were appropriate for the content. *

Yes

No

This session met my expectations based on the session description and learning objectives. *

Yes

No

I observed objective, balanced content that demonstrated no bias in favor of goods or services of a commercial interest. *

Yes

No

Speaker/Moderator was engaging and provided accurate, valuable content *

	Yes	No
Caroline Horner, MD FAAAAI	Caroline Horner, MD FAAAAI - Yes	Caroline Horner, MD FAAAAI - No
Katharine M. Woessner, MD FAAAAI	Katharine M. Woessner, MD FAAAAI - Yes	Katharine M. Woessner, MD FAAAAI - No

If you responded no to any questions, or have other comments about this session, please explain.

Please provide any additional feedback about the faculty in this session:

Leave this field blank